Irinotecan—still an important player in cancer chemotherapy: a comprehensive overview
M Kciuk, B Marciniak, R Kontek - International journal of molecular …, 2020 - mdpi.com
Irinotecan has been used in the treatment of various malignancies for many years. Still, the
knowledge regarding this drug is expanding. The pharmacogenetics of the drug is the …
knowledge regarding this drug is expanding. The pharmacogenetics of the drug is the …
Receptor tyrosine kinases and their signaling pathways as therapeutic targets of curcumin in cancer
S Sudhesh Dev, SA Zainal Abidin… - Frontiers in …, 2021 - frontiersin.org
Receptor tyrosine kinases (RTKs) are transmembrane cell-surface proteins that act as signal
transducers. They regulate essential cellular processes like proliferation, apoptosis …
transducers. They regulate essential cellular processes like proliferation, apoptosis …
Corneal neovascularization: an anti-VEGF therapy review
JH Chang, NK Garg, E Lunde, KY Han, S Jain… - Survey of …, 2012 - Elsevier
Corneal neovascularization is a serious condition that can lead to a profound decline in
vision. The abnormal vessels block light, cause corneal scarring, compromise visual acuity …
vision. The abnormal vessels block light, cause corneal scarring, compromise visual acuity …
Current methods of post-translational modification analysis and their applications in blood cancers
Simple Summary This review discusses current techniques used to study post-translational
protein modifications (PTMs) and their contribution to blood cancer research. Blood cancer …
protein modifications (PTMs) and their contribution to blood cancer research. Blood cancer …
Deep molecular response in chronic myeloid leukemia: the new goal of therapy?
FX Mahon, G Etienne - Clinical Cancer Research, 2014 - AACR
Chronic myeloid leukemia (CML) is caused by formation of the BCR–ABL1 fusion protein.
Tyrosine kinase inhibitors (TKI) that target BCR–ABL1 are now the standard of care for …
Tyrosine kinase inhibitors (TKI) that target BCR–ABL1 are now the standard of care for …
Identification of anticancer peptides from bovine milk proteins and their potential roles in management of cancer: a critical review
Cancer is the most widely recognized reason for human deaths globally. Conventional
anticancer therapies, including chemotherapy and radiation, are very costly and induce …
anticancer therapies, including chemotherapy and radiation, are very costly and induce …
Muscarinic receptor agonists and antagonists: effects on cancer
ER Spindel - Muscarinic receptors, 2012 - Springer
Many epithelial and endothelial cells express a cholinergic autocrine loop in which
acetylcholine acts as a growth factor to stimulate cell growth. Cancers derived from these …
acetylcholine acts as a growth factor to stimulate cell growth. Cancers derived from these …
Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms
M Lejman, K Kuśmierczuk, K Bednarz… - International Journal of …, 2021 - mdpi.com
Targeted therapy has revolutionized the treatment of poor-prognosis pediatric acute
lymphoblastic leukemia (ALL) with specific genetic abnormalities. It is still being described …
lymphoblastic leukemia (ALL) with specific genetic abnormalities. It is still being described …
Kinase scaffold repurposing for neglected disease drug discovery: Discovery of an efficacious, lapatanib-derived lead compound for trypanosomiasis
G Patel, CE Karver, R Behera, PJ Guyett… - Journal of medicinal …, 2013 - ACS Publications
Human African trypanosomiasis (HAT) is a neglected tropical disease caused by the
protozoan parasite Trypanosoma brucei. Because drugs in use against HAT are toxic and …
protozoan parasite Trypanosoma brucei. Because drugs in use against HAT are toxic and …
Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma—Future or the Past?
Simple Summary Renal cell carcinoma (RCC) is the sixth most frequently diagnosed cancer
in men and the tenth in women with a rising incidence. The treatment of metastasized RCC …
in men and the tenth in women with a rising incidence. The treatment of metastasized RCC …